TLR4 and acute respiratory distress syndrome: MiR-223 additionally shows utility in reducing inflammation and preventing the onset of ALI and ARDS by suppressing NLRP3 as well as Toll-like receptor 4 (TLR4)/NF-ҡB pathways in the in vitro model of ALI [148].